Effectiveness of magnesium isoglycyrrhizinate on perioperative hepatic function protection in patients undergoing hepatectomy

Figure 4 Changes in serum alanine aminotransferase and aspartate aminotransferase levels in the group (B2-2) upon treatment with magnesium isoglycyrrhizinate plus other liver protectants vs the control group (B2-3) upon treatment with other liver protectants. A-H: The levels, changes from postoperative day 1, proportions of patients with ≥ 50% reduction in the serum levels of aminotransferase and the proportions of patients who had normalized serum alanine aminotransferase (A-D) and aspartate aminotransferase levels (E-H) post hepatectomy. ^aP < 0.05. ^cP < 0.001. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; POD: Postoperative day; NS: Not significant.